- Filed
- May 8, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 30, 2026 | 7.16M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 7.23M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 7.23M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $184K |
| Capex | Q1 2026 · Mar 31, 2025 | $228K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$2.51M |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | $284K |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $59.78M |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $100.73M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $194.45M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $208.9M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $201.44M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $200.27M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $196.64M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $196.64M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $2.17B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $2.18B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $2.37B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $2.38B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.25 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.20 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.25 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.20 |
| Net Income | Q1 2026 · Mar 31, 2026 | $1.87M |
| Net Income | Q1 2026 · Mar 31, 2025 | $1.52M |